Related references
Note: Only part of the references are listed.Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
Lisa A. Jackson et al.
BMC INFECTIOUS DISEASES (2010)
Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents
Vincenzo Baldo et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
Elizabeth Miller et al.
LANCET (2010)
Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: Do children of all ages respond equally?
Emmanuel B. Walter et al.
VACCINE (2010)
Influenza surveillance in a cohort of HIV-infected children and adolescents immunized against seasonal influenza
Antonella Amendola et al.
VACCINE (2010)
An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses
Guangyu Zhao et al.
VIROLOGY JOURNAL (2010)
Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease
Cinta de Diego et al.
EUROPEAN HEART JOURNAL (2009)
Efficacy of Inactivated Split-Virus Influenza Vaccine against Culture-Confirmed Influenza in Healthy Adults: A Prospective, Randomized, Placebo-Controlled Trial
Jiri Beran et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009.
Seema Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Trivalent Inactivated Influenza Virus Vaccine Given to Two-Month-Old Children An Off-Season Pilot Study
Emmanuel B. Walter et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
Timo Vesikari et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Trivalent inactivated subunit influenza vaccine Influvac®: 25-Year experience of safety and immunogenicity
K. M. Giezeman et al.
VACCINE (2009)
Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus
Gian Vincenzo Zuccotti et al.
VACCINE (2009)
Eleven years of Inflexal® V-a virosomal adjuvanted influenza vaccine
Christian Herzog et al.
VACCINE (2009)
Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: The importance of cross-protection
Filippo Ansaldi et al.
VACCINE (2009)
MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
T. Vesikari et al.
VACCINE (2009)
MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
Michele Pellegrini et al.
VACCINE (2009)
Cell-based influenza vaccines: Progress to date
Jennifer M. Audsley et al.
DRUGS (2008)
Vaccines against epidemic and pandemic influenza
Mary Hoelscher et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy
Alessandra Vigano et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants
Natasha B. Halasa et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination in Children
Douglas M. Fleming et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: A randomized controlled trial in China
Feng Cai Zhu et al.
VACCINE (2008)
The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia
Anthony T. Newall et al.
VACCINE (2008)
Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination
Tetsu Sugimura et al.
VACCINE (2008)
Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age
Robert B. Belshe et al.
VACCINE (2008)
Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly
Iris de Bruijn et al.
VACCINE (2007)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults
Robert B. Belshe et al.
VACCINE (2007)
Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma
Gianvincenzo Zuccotti et al.
VACCINE (2007)
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Noelle-Angelique M. Molinari et al.
VACCINE (2007)
Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children
Susan S. Chiu et al.
PEDIATRICS (2007)
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications
V. Baldo et al.
VACCINE (2007)
Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives
E. Navas et al.
VACCINE (2007)
Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis
Julius Atashili et al.
BMC INFECTIOUS DISEASES (2006)
Influenza vaccination - Health impact and cost effectiveness among adults aged 50 to 64 and 65 and older
Michael V. Maciosek et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2006)
Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming
Rhys S. Allan et al.
IMMUNITY (2006)
Cost-effectiveness of influenza vaccination of healthy children
Heini Salo et al.
VACCINE (2006)
Epidermal DNA vaccine for influenza is immunogenic in humans
Robert J. Drape et al.
VACCINE (2006)
Antibody response to influenza vaccination in the elderly: A quantitative review
K Goodwin et al.
VACCINE (2006)
The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly
YZ Ghendon et al.
EPIDEMIOLOGY AND INFECTION (2006)
Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years
S Esposito et al.
VACCINE (2006)
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
SL Epstein et al.
VACCINE (2005)
Clinical experience with inactivated, virosomal influenza vaccine
IA de Bruijn et al.
VACCINE (2005)
Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children
G Kanra et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Inactivated influenza virus vaccines in children
FL Ruben
CLINICAL INFECTIOUS DISEASES (2004)
Influenza vaccination in children with asthma -: Randomized double-blind placebo-controlled trial
HJ Bueving et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly
BR Ruf et al.
INFECTION (2004)
Influenza vaccination in asthmatic children: effects on quality of life and symptoms
HJ Bueving et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Mapping the antigenic and genetic evolution of influenza virus
DJ Smith et al.
SCIENCE (2004)
Serum antibody responses after intradermal vaccination against influenza
RB Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Dose sparing with intradermal injection of influenza vaccine
RT Kenney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Does influenza vaccination exacerbate asthma in children?
HJ Bueving et al.
VACCINE (2004)
Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines
RJ Cox et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
KL Nichol
VACCINE (2003)
A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: Results from an immunogenicity meta-analysis
A Banzhoff et al.
GERONTOLOGY (2003)
Virosome-mediated delivery of protein antigens to dendritic cells
L Bungener et al.
VACCINE (2002)
A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community
T Vu et al.
VACCINE (2002)
Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults
PA Muennig et al.
CLINICAL INFECTIOUS DISEASES (2001)
Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience
KM Neuzil et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Effectiveness of influenza vaccination in the elderly in a community in Italy
E Crocetti et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2001)
Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis
UB Schaad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Influenza vaccination in children with asthma in Health Maintenance Organizations
P Kramarz et al.
VACCINE (2000)
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
RB Belshe et al.
JOURNAL OF PEDIATRICS (2000)
Influenza and the rates of hospitalization for respiratory disease among infants and young children.
HS Izurieta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.
KM Neuzil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
